Cisco
CSCO
NVIDIA
NVDA
Taiwan Semiconductor
TSM
ASML Holding
ASML
Apple
AAPL
US Stock MarketDetailed Quotes
OLMA Olema Pharmaceuticals
- 4.080
- -0.120-2.86%
Trading Mar 28 12:05 ET
278.80MMarket Cap-1.85P/E (TTM)
4.255High4.000Low64.32KVolume4.230Open4.200Pre Close264.56KTurnover0.16%Turnover RatioLossP/E (Static)68.33MShares16.62052wk High0.68P/B167.71MFloat Cap3.93052wk Low--Dividend TTM41.11MShs Float60.270Historical High--Div YieldTTM6.07%Amplitude2.000Historical Low4.113Avg Price1Lot Size
About Olema Pharmaceuticals Company
Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.
Company Profile
SymbolOLMA
Company NameOlema Pharmaceuticals
Listing DateNov 19, 2020
Issue Price19.00
Founded2006
CEODr. Sean P. Bohen, M.D.,PhD
MarketNASDAQ
Employees96
Fiscal Year Ends12-31
Address780 Brannan Street
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94103
Phone1-415-651-3316
Websitehttp://www.olema.com
Company Executives
- Name
- Position
- Salary
- Dr. Sean P. Bohen, M.D.,PhD
- Director, President and Chief Executive Officer
- 3.15M
- Dr. Naseem Zojwalla, M.D.
- Chief Medical Officer
- 1.30M
- Dr. David C. Myles, PhD
- Chief Discovery and Non-Clinical Development Officer
- --
- Shane Kovacs
- Principal Accounting Officer, Chief Operating and Financial Officer
- 1.55M
- Ian T. Clark
- Chairman of the Board
- 198.65K
- Dr. Cyrus L. Harmon, PhD
- Director
- 1.33M
- Yi Larson
- Independent Director
- 163.15K
- Cynthia M. Butitta
- Independent Director
- 180.15K
- Scott Garland
- Independent Director
- 280.21K
- Andrew S. Rappaport
- Independent Director
- 176.65K
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 158.15K
- Dr. Graham Waley, M.D.,PhD
- Independent Director
- 171.15K
- Dr. Gorjan Hrustanovic, PhD
- Independent Director
- 165.15K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.